ProQR Therapeutics N.V ($PRQR) Insider Trading & Smart Money Activity

ProQR Therapeutics N.V. · Biotechnology · Latest filing Jun 29, 2026

ProQR Therapeutics N.V. ($PRQR) has 1 insider trade and 5 analyst ratings on file. In the last 12 months on the open market, 1 insider bought ($231K) and no insider sold, net +$231K.

Insider buyers (12 mo)
1
Insider sellers (12 mo)
0
Net insider $ (12 mo)
+$231K
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
5

PRQR insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 1 · $231K 0 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All PRQR insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Analyst Evercore ISI Group Reiterates to buy PT $6 -6.0%-5.5% Read
Analyst Jones Trading Reiterates to buy PT $10 +12.4%+13.1% Read
Analyst Jones Trading Reiterates to buy PT $10 +12.4%+13.1% Read
Insider Bart Filius Buy (Open-market buy) 150K sh $231K +12.4%+13.1% Read
Analyst Chardan Capital Reiterates to buy PT $3 +12.4%+13.1% Read
Analyst Chardan Capital Reiterates to buy PT $3 +12.4%+13.1% Read

1W / 1M / 6M = how PRQR moved from the trade or filing date.

Insider trading in PRQR: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Bart Filius 1 +$231K Jun 26, 2026

Analyst ratings on PRQR

DateFirmActionRatingPrice target1W1M6MStory
Evercore ISI Group Reiterates buy $6 -6.0%-5.5% Read
Jones Trading Reiterates buy $10 +12.4%+13.1% Read
Jones Trading Reiterates buy $10 +12.4%+13.1% Read
Chardan Capital Reiterates buy $3 +12.4%+13.1% Read
Chardan Capital Reiterates buy $3 +12.4%+13.1% Read

Frequently asked questions

Are PRQR insiders buying or selling?

Over the last 12 months 1 insider made 1 open-market purchase worth $231K and 0 insiders made 0 open-market sales worth $0, a net +$231K.

What is the latest insider trade in PRQR?

Bart Filius filed a buy (open-market buy) of 150K sh worth $231K on Jun 26, 2026.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text